This Week in Psychedelics - 2.19.21

ThisWeekinPsychedelics.png

Cannabis

  • The US cannabis industry now supports 321,000 full-time jobs (Leafly)

  • North Dakota Lawmakers Approve Marijuana Legalization Bill In Committee (Marijuana Moment)

  • New Mexico Lawmakers Approve Marijuana Legalization Bill In Committee (Marijuana Moment)

  • Minnesota Marijuana Legalization Bill Approved In First Committee Vote (Marijuana Moment)

  • Hawaii Senate Panel Approves Bills To Legalize Marijuana And Increase Decriminalization Limit (Marijuana Moment)

  • North Dakota Marijuana Decriminalization Bill Advances As Activists And Lawmakers Push Legalization Measures (Marijuana Moment)

  • New Jersey Lawmakers’ Marijuana Talks Break Down Months After Voters Approve Legalization (Marijuana Moment)

  • New York Governor To Send Amended Marijuana Legalization Plan To Lawmakers Amid Criticism (Marijuana Moment)

  • Cannabis spurs creative but unrealistic ideas, study shows (Marijuana Business Daily)

  • Maryland Lawmakers Push To Legalize Marijuana And Expunge Convictions (High Times)

  • South Dakota rejects telemedicine for medical marijuana consultations (Marijuana Business Daily)

  • Medical cannabis dependence: A critical review of issues and evidence (Drug Science)

  • Cannabis mixtures studied as treatment for COVID inflammation (Marijuana Business Daily)

  • Study: Adult-Use Marijuana Legalization Laws Associated with Declines in Workers’ Compensation Claims (NORML)

  • NFL Explores How Marijuana And CBD Can Be Used As Opioid Alternatives For Players (Marijuana Moment)

  • ‘Increasingly potent’: Do you have the heart to smoke marijuana? (The Independent)

  • DEA Wants To Know About Applicants’ Hemp And CBD Use, But Only Pre-Legalization (Marijuana Moment)

  • Cannabis Inhalation Associated with Clinical Improvement in Patients with Ulcerative Colitis (NORML)

  • Cannabinoids can improve skin, study says (Marijuana Business Daily)

LSD

Magic Mushrooms

  • New Grant Funds Clinical Trial to Assess Psychedelic as Treatment for Phantom Limb Pain (UC San Diego Health)

  • California Activists Gear Up For 2022 Push To Legalize Psilocybin Mushrooms (Marijuana Moment)

  • Researchers Demand Reparations to Mazatecs for Mushroom “Spirit” (Chacruna)

  • Tryp Therapeutics Launches Clinical Trials to Investigate Psilocybin for Over-Eating Disorders (Psilocybin Alpha)

  • Silo Wellness expands mushroom efforts in Jamaica (Jamaica Observer)

  • PharmaTher Announces Sale of Psilocybin Program (Psilocybin Alpha)

  • Blue Goba Goes Down Temporarily (Psillow)

  • From Magic Mushroom to Forbidden Fungus (and Back) (Reason)

MDMA

  • Mind Medicine Australia challenges TGA Interim Decision (Mind Medicine Australia)

  • Numinus announces milestones in compassionate access trial for MDMA-assisted therapy in collaboration with MAPS Public Benefit Corporation (Psilocybin Alpha)

Ayahuasca

  • Rapid antidepressant effects of the psychedelic ayahuasca linked to changes in inflammatory biomarkers (PsyPost)

  • Ayahuasca Could Help With Grief (Truffle Report)

5-MeO-DMT

  • Jaguar (5-MeO-DMT) Vape Pens (Erowid)

Iboga

Novel Psychoactive Substances

Ketamine

  • The Nuances of Ketamine’s Neurochemistry (Psychedelic Science Review)

  • Off and on: Elijah McClain ketamine investigation now on hold at state health department (KDVR)

Miscellaneous

  • California bill would decriminalize psychedelics, paving the way for medical treatment (The Guardian)

  • GOP Iowa Lawmaker Files Bill To Allow Psilocybin, MDMA And LSD Access For Seriously Ill Patients (Marijuana Moment)

  • Envisioning a psychedelic future for Philadelphia’s USciences as it pairs with Compass Pathways for a Drug Discovery Center (The Philadelphia Inquirer)

  • Washington Lawmakers Approve Drug Decriminalization Bill In Committee Vote (Marijuana Moment)

  • Vermont Lawmakers Prepare Psychedelics And Broader Drug Decriminalization Bills For Introduction (Marijuana Moment)

  • Will the Federal Government Finally Embrace the Psychedelic Revolution? (Rolling Stone)

  • ATMA Launches Canada's First Psychedelic Training Program for Mental Health Professionals that Includes a Legal Psychedelic Experience (Cision)

  • The Faux Shamanism of Jake “Angeli” Chansley (Lucid News)

  • Could the Embrace of Psychedelics Lead to a Mental-Health Revolution? (Vogue)

  • Cocaine, cannabis or ecstasy – whatever your drug, it has an impact on the planet (The Independent)

  • The Psychedelic Stock Liftoff. Why Psychedelics over Cannabis? (Dark Matters)

  • Current Psychedelic Research Lacks Diversity (Volteface)

  • Psychedelics in the Age of Sexual Liberation (The Oak Tree Review)

  • Celebrating 25 Weeks of ‘Women in the History of Psychedelic Plant Medicines’ (Chacruna)

  • Microdosing for Chronic Pain: Does it Actually Help? (DoubleBlind)

  • The Problem and Paradox of Bad Trips – Part 1 (Psychedelic Science Review)

  • Orientation Before Preparation (Psychedelic Frontier)

  • Future Generations Will Condemn the Drug War: Reform Is Urgent and Inevitable (Sydney Criminal Lawyers)

  • Will Health Insurance Ever Cover Psychedelic-Assisted Therapies? (Truffle Report)

  • Alberta’s First Full-Service Psychedelic Therapy Clinic Opens in Calgary, Ushering in a New Era of Hope to Deal with the Growing Mental Health Crisis in Canada (Psilocybin Alpha)

  • Psychedelics and the Queer Art of Survival (Chacruna)

  • Why Psychedelics Are a More 'Compassionate' Way to Treat Trauma (Inverse)

  • Jade Ullmann is Bridging Together Psychedelic Communities (Lucid News)

  • From trippy drugs to therapeutic aids – how psychedelics got their groove back (The Conversation)

  • Rise In Consumer Acceptance of Psychedelic Drug Therapies Is Quickly Increasing (PR Newswire)

  • Could Psychedelic-Assisted Therapy Help Treat Bipolar II Disorder? (Truffle Report)

  • How Psychedelics Can Help Treat Anxiety (Psychedelic Passage)

  • 'Could we treat depression by prescribing patients a psychedelic drug?' (Mirror)

  • A therapist explains what it’s like to give psychedelic-assisted therapy. (Inverse)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.